FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Bajaj Capital Ltd, BP Equities (BP Wealth), Canara Bank Securities Ltd, Mehta Equities and Ventura Securities Limited have given "Apply" recommendation to Niva Bupa Health Insurance IPO. Dilip Davda and Swastika Investmart Ltd have given "May Apply" recommendation to Niva Bupa Health Insurance IPO. Capital Market has "Neutral" view about the IPO. Axis Capital has "Not Rated" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 5 | 2 | 1 | 0 | 1 |
% | 55.56 | 22.22 | 11.11 | 0.00 | 11.11 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Axis Capital | Not Rated | |
Bajaj Capital Ltd | Apply | |
BP Equities (BP Wealth) | Apply | |
Canara Bank Securities Ltd | Apply | |
Capital Market | Neutral | |
Dilip Davda | May Apply | |
Mehta Equities | Apply | |
Swastika Investmart Ltd | May Apply | |
Ventura Securities Limited | Apply |
The Captial Market (CapitalMarket.com) rating for Niva Bupa Health Insurance IPO is 43. Their analysis recommends Avoid, however active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 43 | Avoid, however active risk seekers can try |
[Dilip Davda] The company is one of the leading health insurance company in India and has emerged as the fastest growing company. It turned the corner from FY23, but based on its earnings so far, the issue prima-facie appears aggressively priced. However, considering the recent placement of shares internally between Rs. 67.15 and Rs. 85 per share, the IPO appears well priced. Well-informed investors may park funds for medium to long term. Read detail review...
Niva Bupa Health Insurance Company Limited peer comparison with similar listed entities. (As on March 28, 2024)
Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
---|---|---|---|---|---|---|---|
Niva Bupa Health Insurance Company Limited | 0.51 | 0.5 | 12.06 | 5.68 | |||
Star Health and Allied Insurance Company Limited | 14.48 | 14.19 | 108.35 | 36.97 | 14.35 | 5.03 | Consolidated |
Icici Lombard General Insurance Company Ltd | 39.03 | 38.78 | 242.75 | 45.92 | 17.17 | 6.96 | Consolidated |
The New India Assurance Company Ltd | 6.77 | 6.77 | 132.55 | 35.23 | 5.13 | 1.72 | Consolidated |
Niva Bupa Health Insurance IPO Reviews, analysis and views by popular members. Read Niva Bupa Health Insurance Company Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 3 | 0 | 0 | 1 |
% | 75.00 | 0.00 | 0.00 | 25.00 |
Member | Review |
---|---|
PrahaladSingh Patel |
Apply for Long Term at Upper Price Band I did analysis for Niva Bupa Financial Market November 10, 2024 2:31:30 PM |
chIPOrgarh (300+ Posts) |
Avoid Expensive valuation. November 7, 2024 6:22:10 PM |
CatP |
Apply for Long Term at Upper Price Band Best in class management team. Claims ratio under check. MNC owned company - always get high multiples across sectors November 6, 2024 2:58:35 PM |
Mahesh Kumar Maharana |
Apply for Long Term at Cut-off Price Technical are good November 1, 2024 11:09:05 AM |
Post Recommendation Manage Recommendations
Note:
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|